Stimulating telomerase and increasing telomere length are the most promising ways of increasing life expectancy naturally. It has been proven to work in animal and in vivo studies. Studies have shown that shortened telomeres are responsible for many age-related diseases. They are also predictive of premature death in elderly subjects. Maintaining a high telomerase level slows and prevents the shortening of telomeres. It restores a more youthful T lymphocyte profile.
The efficacy of Cycloastragenol appears to be dose-dependent. People with the shortest telomeres (often the oldest members of society) achieve better and faster results with higher doses, from between 25mg to even 50mg a day.
Cycloastragenol is a triterpenoid saponin isolated from various legume species in the genus Astragalus that is purported to have telomerase activation activity. A preliminary in vitro study on human CD4 and CD8 T cells found that cycloastragenol may moderately increase telomerase activity and inhibit the onset of cellular senescence.[1]
Cycloastragenol: An exciting novel candidate for age‑associated diseases (Review)
See link below for more information:
Cycloastragenol: An exciting novel candidate for age‑associated diseases (Review) (spandidos-publications.com)
Authors:
Yongjie Yu, Limin Zhou, Yajun Yang, Yuyu Liu
Published online on: July 20, 2018
History
Cycloastragenol is a triterpenoid saponin isolated from various legume species in the genus Astragalus that is purported to have telomerase activation activity.
A preliminary in vitro study on human CD4 and CD8 T cells found that cycloastragenol may moderately increase telomerase activity and inhibit the onset of cellular senescence.[1]